SurekhaYadav MD
@shiningsurekha
Followers
202
Following
604
Statuses
237
NucMed. Theranostics. @ DeptofRadiology @UCSF |Tweets are my own
New Delhi, India
Joined December 2010
RT @UCSFimaging: The @PSMAconference will gather leading experts to discuss the latest in PSMA PET imaging & radioligand therapies. Hear fr…
0
6
0
RT @DrMHofman: SPECT deserves RESPECT! @drlouiseemmett makes the argument that it is a powerful tool for theranostics ➤ enabling early,…
0
26
0
RT @thomashopemd: We are excited to host the second PSMA PET conference with @UCLATheranostic and the @PCF_Science in March. The abstract d…
0
10
0
Imagine the future of precision medicine with evidence that is impossible to ignore! Our latest study shows why post-treatment SPECT scans are a must. Next time you’re ordering, let these numbers do the talking!
1) We recently reported our experience with post-treatment SPECT in PSMA RLT and its impact on management. Nearly 50% of patients had a change in treatment! Post-treatment imaging has a huge impact, and allows us to follow disease at each treatment (
1
0
6
Here’s a quick link to the full article for those interested:
0
0
0
RT @UCSFimaging: New in #Theranostics from @UCSFimaging's Drs. Anil Bidkar (@anilbidkar1), Luann Zerefa, Surekha Yadav (@shiningsurekha), H…
0
4
0
Shoutout to the incredible team behind this review @anilbidkar1 @flavell_rob and Co-authors ! Grateful for the opportunity @flavell_rob and to be a part of this project!!
Congrats to @anilbidkar1 @shiningsurekha and co-authors on the timely review on Actinium-225 targeted alpha particle therapy for prostate cancer! Lots of promise for this treatment modality. #Theranostics
0
1
7
RT @CalaisJeremie: We can do better than a fixed set of 6 cycles of LuPSMA at a 6-week time interval ! Great multicenter data of >100 pati…
0
14
0
RT @drlouiseemmett: @thomashopemd @shiningsurekha @UCSFimaging @JournalofNucMed @SNM_MI @NANETS1 A great goal! SPECT/CT after PRRT provides…
0
2
0
Pairing of a promising project with an exceptional mentor @thomashopemd ! Excited and hopeful about the utility of SPECT/CT in #radioligandtherapies @UCSFimaging @JournalofNucMed @NANETS1
In March, @shiningsurekha published our experience on the impact of post-treatment SPECT on patient management. We are trying to move people from thinking about SPECT as only for dosimetry, and focus on its role in response assessment and using it to follow patients over time.
0
1
11
RT @drlouiseemmett: ENZA-p trial @TheLancetOncol Enzalutamide + adaptive-dosed (2 or 4) 177 Lu-PSMA617 vs enza al…
0
44
0
@CalaisJeremie @JournalofNucMed @thomashopemd @CalaisJeremie thanks for the shout out ! Glad you found it relevant. Equal parts of excited and hopeful about the future of SPECT imaging in #theranostics
0
0
0
RT @CalaisJeremie: SPECT images obtained +24h after administration of Lu177 therapy can provide valuable information and can impact patient…
0
11
0
@CalaisJeremie thanks for the shout out ! Glad you found it relevant. Equal parts of excited and hopeful about the future of SPECT imaging in #theranostics
SPECT images obtained +24h after administration of Lu177 therapy can provide valuable information and can impact patient management. #theranostics
@JournalofNucMed @thomashopemd @shiningsurekha
0
0
5
Is EXCITED about: - Upcoming talks at #SNMMI #MidWinterMeeting by some of the distinguished figures in theranostics @thomashopemd @lisabodei @flavell_rob - My talk on Volumetric Analysis in SSTR Imaging - Presenting our results on Impact of Post treatment Imaging in PRRT
0
0
11
RT @thomashopemd: @KateNCUK @ncukcharity The ACTION-1 trial from RayzeBio doesn't include bronchial NETs. But please get the word out abou…
0
11
0
@thomashopemd @PSMAconference @CalaisJeremie @drlouiseemmett @morr316 @CarlosUribeM The cumulative years of experience in managing prostate cancer patients esp #psma #psmarlt this board had is insane!! @PSMAconference has been such an educative feast; It’s not just me a lot of others trainees/early career professionals agree !
0
0
6
RT @urotoday: Evaluation of the primary tumor with PSMA PET: time impact of the #PRIMARY trial. Presented by @drlouiseemmett. Written cover…
0
12
0